The Patent Finder

Enterome S.A.

11 patents currently held · Updated Nov 21, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2037
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Feb 1, 2027
    The maintenance fee for Microbiota sequence variants of tumor-related antigenic epitopes (US 11,712,465) comes due Feb 1, 2027. Unpaid by Aug 2, 2027, it lapses early.
  • 1 fee due Mar 19, 2027
    The maintenance fee for Antigenic Peptides For Treatment Of B-Cell Malignancy (US 11,759,508) comes due Mar 19, 2027. Unpaid by Sep 20, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 12,059,460Immunogenic Compounds for Cancer Therapy
In force
 · Medium confidence
In forceMedium confidence
US 12,263,210Immunogenic compounds for cancer therapy
In force
 · USPTO record
In forceUSPTO record
US 12,364,743Microbiota sequence variants of tumor-related antigenic epitopes
In force
 · USPTO record
In forceUSPTO record
US 12,447,201Immunogenic Compounds For Cancer Therapy
In force
 · Medium confidence
In forceMedium confidence
US 11,478,538Immunogenic Compounds For Cancer Therapy
In force
 · Medium confidence
In forceMedium confidence
US 11,478,537Immunogenic compounds for cancer therapy
In force
 · USPTO record
In forceUSPTO record
US 12,766,190Antigenic Peptides For Prevention And Treatment Of Cancer
In force
 · High confidence
In forceHigh confidence
US 11,712,465Microbiota sequence variants of tumor-related antigenic epitopes
In force
 · USPTO record
In forceUSPTO record
US 11,759,508Antigenic Peptides For Treatment Of B-Cell Malignancy
In force
 · High confidence
In forceHigh confidence
US 12,016,910Antigenic Peptides For Prevention And Treatment Of Cancer
In force
 · High confidence
In forceHigh confidence
10 of 11 patents shown.
Pro members see all 11.
Pro members: see all 11 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 1 abandoned · 3 no status recorded

Showing 1 to 7 of 7, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. Where no title is shown, the bulk publication record carries none and this site holds no USPTO file history for that application.

ApplicationTitleFiledStatus
18/852,118Antigenic Peptides for Prevention and Treatment of CancerMar 30, 2023Pending
18/291,050IL-10 Inducing Polypeptides and Uses ThereofJul 26, 2022Pending
17/794,085Jan 22, 2021No status recorded
17/794,082Microbiota-Derived Proteins Inducing Il-10 Release From Human Cells And Uses ThereofJan 22, 2021Pending
17/768,757Immunogenic Compounds For Treatment Of Adrenal CancerOct 16, 2020Abandoned
17/043,197Apr 11, 2019No status recorded
16/753,657Oct 9, 2018No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited